Fig. 2From: Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot studyAfamin concentrations in the mid-trimester cohort (between gestational day 44 and 272). Serum concentrations of afamin among patients with gestational diabetes mellitus (GDM) treated with insulin (iGDM; n = 12), treated with dietary intervention (dGDM; n = 17) and control subjects (n = 76) adjusted for gestational age and body-mass-index (BMI)Back to article page